Obstetrics, gynecology and reproductive medicine guidelines

Hepatitis

PubMed Free Full Text

Hepatitis B: prevention, treatment, vaccine

Australia

• Department of Health and Ageing
  • Hepatitis B [2008]

Bangladesh

• Bangladesh Liver Journal
  • Guideline for treating hepatitis B virus infection in Bangladesh [2009]

Canada

• Public Health Agency of Canada
  • Hepatitis B

China

• Chinese Medical Journal
  • Guideline on prevention and treatment of chronic hepatitis [2007]

International

• Cochrane Library
  • Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B
  • Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)
  • Chinese medicinal herbs for chronic hepatitis B
  • Chinese medicinal herbs for asymptomatic carriers of hepatitis B virus infection
  • Bicyclol for chronic hepatitis B

• Program for Appropriate Technology in Health (PATH)
  • Advanced Immunization Management (AIM) e-Learning Website: Hepatitis B [2010]

Netherlands

• Health Council of the Netherlands
  • General vaccination against hepatitis B revisited [2009]
  • Vaccination of children against hepatitis B [2003]

United Kingdom

• British Medical Association
  • Hepatitis B vaccination in childhood - a briefing from the Board of Science [2007]

• Department of Health UK
  • Hepatitis B infected healthcare workers and antiviral therapy [2007]
  • Hepatitis B immunisation of homosexual and bisexual men attending GUM clinics: provision of extra vaccine [2002]

• Health Technology Assessment
  • Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection [2010]
  • Telbivudine for the treatment of chronic hepatitis B infection [2009]
  • Entecavir for the treatment of chronic hepatitis B infection [2009]
  • Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation [2009]

• National Institute for Health and Clinical Excellence
  • Hepatitis B - tenofovir disoproxil fumarate [2009]
  • Hepatitis B - telbivudine [2008]
  • Hepatitis B - entecavir [2008]
  • Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alpha-2a [2006]

United States of America

• CDC Vaccine Safety
  • Hepatitis B and Multiple Sclerosis ( MS) - Vaccine Safety

• CDC Vaccines
  • Hepatitis B Vaccination

• Centers for Disease Control and Prevention
  • Use of Hepatitis B Vaccination for Adults with Diabetes Mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP) [2011]
  • A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of Adults [2006]
  • Postexposure Prophylaxis of Persons with Discrete Identifiable Exposures to Hepatitis B Virus (HBV) [2005]
  • Immunization Management Issues [2005]
  • Case Finding and Management of Hepatitis B Surface Antigen (HBsAg)--Positive Persons During Delivery of Vaccination Services [2005]
  • A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Part 1: Immunization of Infants, Children, and Adolescents [2005]
  • Impact of the 1999 AAP/USPHS Joint Statement on Thimerosal in Vaccines on Infant Hepatitis B Vaccination Practices [2001]

• Hepatitis B Foundation
  • Treatment of Children With Chronic Hepatitis B Virus Infection in the United States: Patient Selection and Therapeutic Options [2010]

• National Guideline Clearinghouse
  • Tenofovir disoproxil for the treatment of chronic hepatitis B. National Institute for Health and Clinical Excellence (NICE) [2009]
  • Telbivudine for the treatment of chronic hepatitis B. National Institute for Health and Clinical Excellence (NICE) [2008]
  • Entecavir for the treatment of chronic hepatitis B. National Institute for Health and Clinical Excellence (NICE) [2008]

• National Institutes of Health
  • Antiviral Therapy for Adults With Chronic Hepatitis B: A Systematic Review for a National Institutes of Health Consensus Development Conference [2009]

WHO

• World Health Organization
  • Documenting the impact of Hepatitis B immunization: best practices for conducting a serosurvey [2011]
  • Hepatitis B [2003]
  • Hepatitis B vaccination and rheumatoid arthritis
  • Hepatitis B vaccination and multiple sclerosis
  • Hepatitis B vaccination and chronic fatigue syndrome
  • Hepatitis B and leukaemia

Articles in journals

• Annals of Clinical Microbiology and Antimicrobials
  • Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues [2006]

• Antiviral Research
  • Fitness and infectivity of drug-resistant and cross-resistant hepatitis B virus mutants: why and how is it studied? [2010]

• Asian Pacific Journal of Cancer Prevention
  • Eliminating the threat of chronic hepatitis B in the Asian and Pacific Islander community: a call to action [2009]

• BioScience Trends
  • Traditional Chinese medicine and related active compounds against hepatitis B virus infection [2010]

• British Medical Journal
  • Preventing and treating hepatitis B infection [2004]

• Bulletin of the World Health Organization
  • Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization? [2010]

• Canadian Medical Association Journal
  • Hepatitis B immunization strategies: timing is everything [2009]

• Cancer Epidemiology Biomarkers & Prevention
  • Global Control of Primary Hepatocellular Carcinoma with Hepatitis B Vaccine: The Contributions of Research in Taiwan [2003]

• Chinese Medical Journal
  • Vaccination against hepatitis B: the Chinese experience [2009]

• Cleveland Clinic Journal of Medicine
  • Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment [2009]

• Gastroentérologie clinique et biologique
  • Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials [2009]
  • Analogs and fibrosis regression in hepatitis B [2009]

• Hepatobiliary & Pancreatic Diseases International
  • Clinical management of hepatitis B virus infection correlated with liver transplantation [2010]

• Hepatology
  • Contemporary Clinical Research of Traditional Chinese Medicines for Chronic Hepatitis B in China: An Analytical Review [2010]
  • Monitoring During and After Antiviral Therapy for Hepatitis B [2009]
  • Antiviral Resistance and Hepatitis B Therapy [2009]

• Journal of Antimicrobial Chemotherapy
  • Antiviral therapy for chronic hepatitis B: are we doing any good to patients? [2009]
  • The mechanisms of action of antivirals against hepatitis B virus infection [2003]
  • Hepatitis B virus: old, new and future approaches to antiviral treatment [2003]
  • Current and future antiviral agents for chronic hepatitis B [2003]

• Journal of Infectious Diseases
  • Hepatitis B Virus Kinetics Under Antiviral Therapy Sheds Light on Differences in Hepatitis B e Antigen Positive and Negative Infections [2010]

• Medical Journal of Australia
  • Why do we not yet have combination chemotherapy for chronic hepatitis B? [2007]

• Saudi Journal of Kidney Diseases and Transplantation
  • Implementing strategies for hepatitis B vaccination [2010]

• Virology Journal
  • Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic review [2010]
  • Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis [2009]
  • Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus [2009]

• World Journal of Gastroenterology
  • Hepatitis B virus infection and renal transplantation [2010]
  • Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation [2010]
  • Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation [2009]
  • Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection [2006]

{Related topics}

• Guidelines
  • Hepatitis B